Forecasting Future Advances Across Oncology

Season 4 Episode 24  ·  Jan 21, 2021, 09:39 PM
Headliner
Share
Subscribe

In our exclusive interviews, each expert discussed their expectations for research and drug development in oncology in the new year.

Share
Subscribe
Next
FDA Approval Insights: Nivolumab/Cabozantinib in Advanced RCC
Top episodes
DeNunzio Describes the Advantages of Proton Beam Therapy in Oncology
by OncLive® On Air
FDA Approval Insights: Amivantamab and Mobocertinib in EGFR Exon 20 Insertion+ NSCLC
by OncLive® On Air
Milhem Talks Mechanism of Action, Delivery Methodology, and Ongoing Trials With RP1
by OncLive® On Air